Lucem Health

We’re headed to !

Holly Taylor, GM of Strategic Partnerships at Lucem Health, will be in New Orleans sharing how AI-enabled early detection can prevent avoidable DKA crises, and how proactive screening is key to preserving vital beta-cell function.

Because when it comes to type 1 , the first sign of disease should not be a life-threatening emergency.

Attending ? Connect with Holly in the 2026 Mobile App to continue the conversation.

Lucem Health is heading to New Orleans for 2026!

As the industry continues to advance new therapies, screening approaches, and standards of care, one question remains: how do we identify more people with before they experience a preventable crisis?

The Lucem Health team will be onsite discussing proactive screening, earlier intervention, patient engagement, and the role of -enabled precision health programs in helping health systems find and support at-risk patients sooner.

Attending ADA 2026? We'd love to connect. Reach out to Holly Taylor or Susan (Waters) Reagan to schedule time with our team.

What if the first sign of Type 1 diabetes wasn’t a life-threatening emergency?

We have guidelines for proactive screening—but operationalizing and scaling them is a major challenge. Healthcare needs a way to identify risk that standard protocols might miss.

Join Monica Bianco, MD, and Michael Haller, MD, and Holly Taylor to learn how predictive can pinpoint T1D risk beyond current guidelines and help prevent before it happens. Register now: https://hubs.ly/Q04gDT-P0

🗓️ June 17 | 12 PM ET

Most T1D cases are still first caught during a DKA crisis — a preventable emergency with real risk of death and ICU admission.

The clinical case for earlier identification isn't just compelling. It's actionable.

Join Lucem Health on Wednesday, June 17 from 12–1 PM ET for "Guidelines Aren't Enough: Rethinking How We Find Type 1 Diabetes Before DKA."

In this expert-led webinar, you'll walk away with:

* Proactive screening strategies you can apply in your practice
* Tools to address diagnostic inequities affecting at-risk populations
* A framework for beta cell preservation and earlier intervention
* How emerging diagnostics and predictive AI are closing the identification-to-intervention gap

This isn't just a conversation about challenging the status quo — it's a roadmap for what to do differently.

Register here: https://hubs.ly/Q04g5p8R0